Scribd
Upload
315 views5 pages

Biocon Balance Sheet

- Biocon is an Indian biopharmaceutical company that produces biosimilar medicines. - The document provides financial information from Biocon's standalone balance sheets and profit & loss accounts from March 2016 to March 2020. - It shows that over this period Biocon has increased total assets from Rs. 7,098 crore to Rs. 8,311 crore, increased total shareholder funds from Rs. 5,997 crore to Rs. 7,537 crore, and increased net profit from Rs. 369 crore to Rs. 441 crore.

Uploaded by

Sweety Roy
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
315 views5 pages

Biocon Balance Sheet

- Biocon is an Indian biopharmaceutical company that produces biosimilar medicines. - The document provides financial information from Biocon's standalone balance sheets and profit & loss accounts from March 2016 to March 2020. - It shows that over this period Biocon has increased total assets from Rs. 7,098 crore to Rs. 8,311 crore, increased total shareholder funds from Rs. 5,997 crore to Rs. 7,537 crore, and increased net profit from Rs. 369 crore to Rs. 441 crore.

Uploaded by

Sweety Roy
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 5

Biocon

Standalone Balance Sheet ------------------- in Rs. Cr. -------------------


  Mar 20 Mar 19 Mar 18 Mar 17 Mar 16

  12 mths 12 mths 12 mths 12 mths 12 mths

EQUITIES AND LIABILITIES


SHAREHOLDER'S FUNDS
Equity Share Capital 600.00 300.00 300.00 100.00 100.00
Total Share Capital 600.00 300.00 300.00 100.00 100.00
Revaluation Reserves 0.90 0.90 0.90 0.90 0.90
Reserves and Surplus 6,936.40 6,814.50 6,437.70 6,440.20 5,895.70
Total Reserves and Surplus 6,937.30 6,815.40 6,438.60 6,441.10 5,896.60
Total Shareholders Funds 7,537.30 7,115.40 6,738.60 6,541.10 5,996.60
NON-CURRENT LIABILITIES
Long Term Borrowings 0.70 1.40 67.20 132.40 136.50
Deferred Tax Liabilities [Net] 0.00 0.00 0.00 0.00 0.90
Other Long Term Liabilities 23.40 105.50 72.30 76.90 92.00
Long Term Provisions 21.40 24.80 17.20 13.30 9.50
Total Non-Current Liabilities 45.50 131.70 156.70 222.60 238.90
CURRENT LIABILITIES
Short Term Borrowings 0.00 0.00 0.00 0.00 225.50
Trade Payables 521.20 643.90 579.70 450.50 394.40
Other Current Liabilities 182.40 294.60 220.30 222.70 214.20
Short Term Provisions 24.40 54.80 31.60 32.00 28.50
Total Current Liabilities 728.00 993.30 831.60 705.20 862.60
Total Capital And Liabilities 8,310.80 8,240.40 7,726.90 7,468.90 7,098.10
ASSETS
NON-CURRENT ASSETS
Tangible Assets 659.00 1,029.10 834.10 864.90 859.60
Intangible Assets 61.70 30.10 24.70 29.20 34.20
Capital Work-In-Progress 151.90 254.50 318.50 240.80 172.30
Other Assets 72.50 41.90 43.80 43.90 43.90
Fixed Assets 945.10 1,355.60 1,221.10 1,178.80 1,110.00
Non-Current Investments 4,814.00 3,902.80 3,745.20 3,363.50 3,210.60
Deferred Tax Assets [Net] 179.50 201.90 102.20 105.40 0.00
Long Term Loans And Advances 156.70 106.60 281.70 192.30 158.40
Other Non-Current Assets 131.80 227.10 319.00 250.40 248.00
Total Non-Current Assets 6,227.10 5,794.00 5,669.20 5,090.40 4,727.00
CURRENT ASSETS
Current Investments 138.80 113.40 453.80 524.70 598.30
Inventories 534.70 801.90 561.70 539.60 504.60
Trade Receivables 573.20 901.80 739.90 798.20 503.80
Cash And Cash Equivalents 375.30 356.00 196.90 382.90 643.00
Short Term Loans And Advances 100.60 91.80 0.00 0.00 0.00
OtherCurrentAssets 361.10 181.50 105.40 133.10 121.40
Total Current Assets 2,083.70 2,446.40 2,057.70 2,378.50 2,371.10
Total Assets 8,310.80 8,240.40 7,726.90 7,468.90 7,098.10
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities 2,203.70 1,932.80 1,797.70 1,708.60 1,644.30
CIF VALUE OF IMPORTS
Raw Materials 0.00 0.00 0.00 0.00 556.10
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 6.10
Trade/Other Goods 0.00 0.00 0.00 0.00 57.80
Capital Goods 0.00 0.00 0.00 0.00 97.50
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency 847.40 1,039.90 734.80 789.90 818.20
REMITTANCES IN FOREIGN CURRENCIES
FOR DIVIDENDS
Dividend Remittance In Foreign
- - - - 21.00
Currency
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods - - - - -
Other Earnings 327.90 510.70 470.90 509.00 343.20
BONUS DETAILS
Bonus Equity Share Capital 293.47 293.47 293.47 93.47 93.47
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted
6,798.30 8,374.10 8,672.40 7,562.20 5,580.00
Market Value
Non-Current Investments Unquoted
2,149.80 1,236.80 1,022.00 640.30 487.20
Book Value
CURRENT INVESTMENTS
Current Investments Quoted Market
- - - - -
Value
Current Investments Unquoted Book
80.00 50.00 145.90 212.00 598.30
Value
Biocon
Standalone Profit & Loss
------------------- in Rs. Cr. -------------------
account
  Mar 20 Mar 19 Mar 18 Mar 17 Mar 16

  12 mths 12 mths 12 mths 12 mths 12 mths

INCOME
Revenue From Operations [Gross] 1,815.10 2,640.20 2,215.30 2,408.60 2,163.30
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 6.30 30.50 33.60
Revenue From Operations [Net] 1,815.10 2,640.20 2,209.00 2,378.10 2,129.70
Other Operating Revenues 173.30 244.50 210.20 209.80 172.10
Total Operating Revenues 1,988.40 2,884.70 2,419.20 2,587.90 2,301.80
Other Income 201.70 117.50 124.70 98.80 173.10
Total Revenue 2,190.10 3,002.20 2,543.90 2,686.70 2,474.90
EXPENSES
Cost Of Materials Consumed 858.20 1,278.50 958.70 991.50 947.90
Purchase Of Stock-In Trade 0.90 125.40 92.50 90.20 76.00
Changes In Inventories Of FG,WIP
-31.40 -147.10 -1.80 -46.50 -36.40
And Stock-In Trade
Employee Benefit Expenses 344.80 510.30 408.60 365.00 321.90
Finance Costs 1.20 2.60 1.00 3.80 1.90
Depreciation And Amortisation
98.00 147.10 136.10 150.60 139.70
Expenses
Other Expenses 529.90 732.00 643.00 595.90 575.40
Total Expenses 1,801.60 2,648.80 2,238.10 2,150.50 2,026.40
  Mar 20 Mar 19 Mar 18 Mar 17 Mar 16

  12 mths 12 mths 12 mths 12 mths 12 mths

Profit/Loss Before Exceptional,


388.50 353.40 305.80 536.20 448.50
ExtraOrdinary Items And Tax
Exceptional Items 159.70 198.70 0.00 0.00 110.90
Profit/Loss Before Tax 548.20 552.10 305.80 536.20 559.40
Tax Expenses-Continued Operations
Current Tax 85.70 141.90 60.60 126.90 217.50
Less: MAT Credit Entitlement -18.70 68.40 -6.20 117.20 0.00
Deferred Tax 7.50 -14.10 0.50 7.20 -26.70
Total Tax Expenses 111.90 59.40 67.30 16.90 190.80
Profit/Loss After Tax And Before
436.30 492.70 238.50 519.30 368.60
ExtraOrdinary Items
Profit/Loss From Continuing
436.30 492.70 238.50 519.30 368.60
Operations
Profit Loss From Discontinuing
11.70 0.00 0.00 0.00 0.00
Operations
Total Tax Expenses Discontinuing
7.10 0.00 0.00 0.00 0.00
Operations
Net Profit Loss From Discontinuing
4.60 0.00 0.00 0.00 0.00
Operations
Profit/Loss For The Period 440.90 492.70 238.50 519.30 368.60
  Mar 20 Mar 19 Mar 18 Mar 17 Mar 16

  12 mths 12 mths 12 mths 12 mths 12 mths

OTHER ADDITIONAL INFORMATION


EARNINGS PER SHARE
Basic EPS (Rs.) 3.68 8.33 4.04 26.45 18.78
Diluted EPS (Rs.) 3.67 8.27 4.02 26.27 18.76
VALUE OF IMPORTED AND INDIGENIOUS
RAW MATERIALS
STORES, SPARES AND LOOSE TOOLS
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 60.10 69.40 69.30 0.00 110.70
Equity Dividend Rate (%) 10.00 10.00 20.00 20.00 100.00
Biocon
Cash Flow ------------------- in Rs. Cr. -------------------
  Mar '20 Mar '19 Mar '18 Mar '17 Mar '16

  12 mths 12 mths 12 mths 12 mths 12 mths

Net Profit Before Tax 436.30 492.70 238.50 519.30 368.60


Net Cash From Operating Activities 387.10 109.50 355.20 185.80 208.50
Net Cash (used in)/from
-212.90 310.90 -555.50 110.40 -321.10
Investing Activities
Net Cash (used in)/from Financing
-128.90 -208.20 -54.60 -238.30 73.00
Activities
Net (decrease)/increase In Cash and
69.30 216.60 -252.50 51.50 -31.80
Cash Equivalents
Opening Cash & Cash Equivalents 305.70 89.10 341.60 290.10 321.90
Closing Cash & Cash Equivalents 375.00 305.70 89.10 341.60 290.10

You might also like